RWJ University Hospital Administers 2nd Dose Of COVID-19 Vaccine To High-Risk Frontline Employees

January 12, 2021

See previous related story here: RWJ University Hospital Hamilton Administers First COVID-19 Vaccinations This Morning To Healthcare Workers

HAMILTON TOWNSHIP, NJ (MERCER)–Twenty-one days after the first COVID-19 vaccines were given to front-line staff, Robert Wood Johnson University Hospital (RWJUH) Hamilton, an RWJBarnabas Health facility, 1 Hamilton Health Place, Hamilton, NJ, administered the second dose of the Pfizer-BioNTech vaccine to the first high-risk employees to receive it on December 20, 2020. The hospital has taken diligent measures to ensure staff receive plenty of notification to schedule and receive their second dose.

After her second dose was administered, Victoria Bradeis, a respiratory therapist and the first RWJUH Hamilton employee to receive the vaccine, said, “I’m feeling great and I’m so thankful to everyone who contributed to making this vaccine happen.”

Robert Wood Johnson University Hospital Hamilton’s employee vaccine clinic has been running daily since the first doses were administered on December 21, 2020. In the past week, the hospital began vaccinating their non-frontline team workers. Employees continue to wear masks, practice proper hand hygiene and practice social distancing, even after receiving their vaccinations, as advised by the CDC.

About Robert Wood Johnson Hospital Hamilton

Located in Hamilton Township, New Jersey, Robert Wood Johnson University Hospital Hamilton, an RWJBarnabas Health facility, serves communities within a five-county area and includes an acute care hospital, cancer center, affiliated medical group, Lakeview Child Centers and the RWJ Fitness & Wellness Center. RWJBarnabas Health and Robert Wood Johnson University Hospital Hamilton, in partnership with Rutgers Cancer Institute of New Jersey – the state’s only NCI-designated Comprehensive Cancer Center – brings a world class team of researchers and specialists to fight alongside you, providing close-to-home access to the latest treatment and clinical trials. For more information, visit us at